ADAR1 Capital Management, LLC
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1940272
AUSTIN, TX
Position in AMLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,879,028
-$5,029,367 QoQ
Shares Held
494,378
-50.6% QoQ
Ownership
0.444%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#40
of 205 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Derivatives in AMLX
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$720,196
PutShares
40,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $25,810,127 across 10 Drug Manufacturers - Specialty & Generic names. AMLX ranks #2 (34.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
277,848 | $9,413,490 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
494,378 | $8,879,028 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
26,913 | $1,721,086 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
133,000 | $1,330,000 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
27,842 | $1,294,931 | |
| 6 | INM |
InMed Pharmaceuticals Inc.
|
800,000 | $1,240,000 | |
| 7 | TXMD |
TherapeuticsMD, Inc.
|
342,447 | $756,807 | |
| 8 | EOLS |
Evolus, Inc.
|
100,000 | $694,000 |
All Filings in AMLX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,879,028 | 494,378 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $720,196 | 40,100 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $13,908,395 | 1,000,604 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $10,755,500 | 890,356 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $11,771,685 | 866,202 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,724,697 | 1,205,101 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,209,417 | 1,471,587 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $37,800 | 10,000 | Call | Sole | 2025-02-13 | |
| 2024-09-30 | $715,735 | 220,906 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $32,400 | 10,000 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $19,000 | 10,000 | Call | Sole | 2024-08-13 | |
| 2024-06-30 | $203,881 | 107,306 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $110,356 | 38,858 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $90,312 | 31,800 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $210,444 | 74,100 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $176,640 | 12,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $468,096 | 31,800 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $1,141,653 | 77,558 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||